ClinicalTrials.gg
Not yet recruitingNCT07935460Updated Nov 13, 2026

Infection Rate With Intramedullary Interlocking Nail Versus Plate Fixation in Open Tibial Fractures

An interventional study of Intramedullary Interlocking Nail Fixation and Plate Fixation in Open Tibial Fracture, sponsored by Allied Hospital Faisalabad. Not yet recruiting. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Allied Hospital Faisalabad · Not applicable, Interventional, and Treatment

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
170
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Open fractures of the tibia are at risk of infection because the injury damages the surrounding soft tissues. This study will compare the frequency of postoperative infection in patients with Gustilo-Anderson type I and II open tibial shaft fractures treated with intramedullary interlocking nail (ILN) fixation or plate fixation after three days of intravenous prophylactic antibiotic therapy.

A total of 170 patients aged 18-60 years will be included and randomly allocated into two groups of 85 patients each. Group A will undergo ILN fixation, while Group B will undergo plate fixation. Patients will be monitored for signs of infection, including pain, redness, swelling, and wound discharge, during hospital stay and follow-up. The main outcome will be the presence of postoperative infection within three months of surgery.

The findings may help clinicians compare infection rates between these two fixation methods in open tibial shaft fractures.

02

Conditions studied

  • Open Tibial Fracture

Browse trials for

03

In context

Tibial Fractures

136 studies on the registry are indexed under Tibial Fractures; 38 are open to participants now.

This study's planned enrollment of 170 is above the median of 66 across 92 interventional studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Allied Hospital Faisalabad is the lead sponsor of 13 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria

    • Patients aged 18-60 years.
    • Both genders.
    • Gustilo-Anderson type I and II open tibial shaft fractures.
    • Patients receiving three days of intravenous antibiotic therapy prior to definitive fixation.

Exclusion Criteria:

    • Gustilo-Anderson type III fractures.

      • Pathological fractures.
      • Polytrauma patients.
      • Patients with diabetes mellitus, , or peripheral vascular disease.
      • Previous surgery on the affected limb
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
170 participants (estimated)

Study arms

  • Experimental
    Arm 1Intramedullary Interlocking Nail Fixation

    Patients will undergo surgical fixation of open tibial fractures using an intramedullary interlocking nail.

    Procedure: Intramedullary Interlocking Nail Fixation

  • Active comparator
    Arm 2 Plate Fixation

    Patients will undergo surgical fixation of open tibial fractures using plate fixation.

    Procedure: Plate Fixation

Interventions

  • ProcedureIntramedullary Interlocking Nail Fixation

    Surgical fixation of open tibial fractures using an intramedullary interlocking nail.

  • ProcedurePlate Fixation

    Surgical fixation of open tibial fractures using plate and screw fixation.

06

What researchers measure

Primary outcomes

  1. Frequency of Postoperative Infection

    Postoperative infection will be assessed by the presence of clinical signs of infection, including pain, redness, swelling, and wound discharge, with or without a positive wound culture. Infection rates will be compared between patients treated with intramedullary interlocking nail fixation and plate fixation.

    Time frame: Within 3 months after surgery

Secondary outcomes

  1. Postoperative Pain Score

    Postoperative pain will be assessed using the Visual Analog Scale (VAS) and compared between the two treatment groups.

    Time frame: Third postoperative day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers. The data will be kept confidential and used only for the purposes of this research study. Access to study data will be restricted to authorized members of the research team.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jul 2027, 8 months later.

Of 39 interventional studies with no phase under Tibial Fractures, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 80. This study's planned 8 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 8, 2026
First posted
Nov 13, 2026
StartEst.
Nov 23, 2026
Primary completionEst.
Jul 23, 2027
CompletionEst.
Aug 23, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07935460
Lead sponsor
Allied Hospital Faisalabad
Responsible party
Muhammad Asif Khan (Postgraduate Resident in Orthopedic Surgery, Allied Hospital Faisalabad) — Principal investigator
First posted
Nov 13, 2026
Start date
Nov 23, 2026 (estimated)
Primary completion
Jul 23, 2027 (estimated)
Completion
Aug 23, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Muhammad Asif Asif Khan, post graduate trainee orthopa
Contact
wazirkhancr768@gmail.com
+923012996395

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion